Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
adverse drug reaction
aggression
agitation
angiography, cerebral
autonomic dysfunction
bath salts, psychoactive
behavior, combative
behavioral disorder
behavioral disorder, acute
cannabinoids
cannabinoids, synthetic
CAT scan, abnormal
cerebrovascular accident
Clinical Pathologic Conference(C.P.C.)
cluster, geographic
complications
confusion
creatinine, elevated
delirium
delusion
designer drugs
drowsiness
drug abuse
drug abuse, toxic screen In
drug induced neurologic disorders
drug overdose
efficacy
encephalopathy
euphoria
hallucination
hallucinogens
intracerebral hemorrhage
lactic acidemia
marihuana
mental status, abnormal
methcathinone
mortality
nabilone
neurologic complications
neurotoxin
paranoia
Parkinson disease
Parkinson disease, nonmotor problems of
Parkinson disease, treatment of
psychosis
renal failure
renal failure, acute
rhabdomyolysis
safety
seizure
self harm
spice
stimulant drugs
stuporous
subarachnoid hemorrhage
sympathomimetic drugs
toxic encephalopathy
treatment of neurologic disorder
urine test in toxic screen
vasospasm
vasospasm, cerebral
violent behavior
zombie
Showing articles 0 to 50 of 6709 Next >>

Non-Motor Symptoms in Parkinsons Disease are Reduced by Nabilone
Ann Neurol 88:712-722, Peball, M.,et al, 2020

"Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
NEJM 376-235-242, Adams, A.J.,et al, 2017

Synthetic Cannabinoid-Related Illnesses and Deaths
NEJM 373:103-107, Trecki, J.,et al, 2015

Hemorrhagic Stroke Following Use of the Synthetic Marijuana "Spice"
Neurol 85:1177-1179, Rose, D.Z.,et al, 2015

Disorders of the Nervous System Caused by Drugs, Toxins, and Chemical Agents, Marijuana
Adams & Victors Principles of Neurology Ch 43, pg 1214, Ropper, A.H.,et al, 2014

Clinicopathologic Conference, Methcathinone (Bath Salts) Intoxication
NEJM 369:2536-2545, Case 40-2013, 2013

Spectrum of Intracranial Hemorrhages in Cerebral Venous Thrombosis, A Pictorial Case Series and Review of Pathophysiology and Management
Neurologist 30:45-51, Jha,S.,et al, 2025

Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients with Moyamoya Disease
Neurol 104:e210243, Chen,H.,et al, 2025

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

Stroke-Like Migraine Attacks After Radiation Therapy Syndrome
Neurol 104:e210203, Lubotzky,A.,t al, 2025

FUTURE-AI: International Consensus Guideline for Trustworthy and Deployable Artificial Intelligence in Healthcare
BMJ 388:e081554, Lekadir,K.,et al, 2025

A 32 Year-Old Woman with Recurrent Intracerebral Hemorrhages
Neurol 104:e213422, Hindsholm,M.F.,et al, 2025

Black Turbinate Sign as an Early Clue of Rhino-Orbital-Cerebral Mucormycosis
Neurol 104:e210202, Xie,J.S.,et al, 2025

Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025

Methamphetamine-Induced Basal Ganglia Toxicity Presenting as Parkinsonism
Neurol 104:e213365, Yi,M.Y.,et al, 2025

Addressing Systemic Complications of Acute Stroke: A Scientific Statement From the American Heart Association
Stroke 56:e15-e29, Kumar,S.,et al, 2025

Commonly Used Interventional Procedures for Non-Cancer Chronic Spine Pain: A Clinical Practice Guideline
BMJ 388:e079970, Busse,J.W.,et al, 2025

Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma
NEJM 392:855-864, 918, Fiorella,D.,et al, 2025

Juvenile-Onset Dopa-Responsive Dystonia-Until It Isnt
Neurol 104:e213436, Paredes,N.C.,et al, 2025

Seizures, Driver Licensure, and Medical Reporting
Neurol 104:e213459, Tolchin,B.,et al, 2025

Calcitonin Gene-Related Peptide-Targeted Therapy in Migraine: Current Role and Future Perspectives
Lancet 405:1014-1026, Versijpt,J.,et al, 2025

Severe Myotonic Crisis Resembling Malignant Hyperthermia
Neurol 104:e213497, Wadhwani,A.R.,et al, 2025

Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025

Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025

Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025

Left Atrial Appendage Closure After Ablation for Atrial Fibrillation
NEJM 392:1277-1287, Wazni,O.M.,et al, 2025

"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025

Chronic Neuropsychiatric Sequelae Associated with Kambo Intoxication
JAMA Neurol 82:418-419, Jauregui,R.,et al, 2025

Long-Term Effects of Antidarsagene Autotemcel for Metachromatic Leukodystrophy
NEJM 392:1609-1620, Fumagalli,F.,et al, 2025

Anticoagulation or Antiplatelet Therapy for Device-Detected Atrial Fibrillation
NEJM 392:1749-1751, Gorey,S., 2025

Postprocedural Brachial Neuritis:Clinical, Electrodiagnostic, and Neuroimaging Features
AJNR 46:1050-1055, Ambati,V.S.,et al, 2025

Validation of an Artificial Intelligence-Powered Virtual Assistant for Emergency Triage in Neurology
Neurologist 30:155-163, Alessandro,L.,et al, 2025

Progress Toward Mitigating Disability Progression in Multiple Sclerosis
NEJM 392:1966-1968, Calabresi,P.A., 2025

General AI May Revolutionize Neurology 0 Or It Might be Bad
JAMA Neurol doi 10.1001/JAMANEUROL.2025.0905, Westover,M.B. & Westover,A.M., 2025

Upadacitinib - An Up-and-Comer for Treatment of Giant-Cell Arteritis
NEJM 392:2062-2064, Koster,M.J. & Warrington,K.J., 2025

Comprehensive Analysis of Neurologic Complications following Transradial Cerebral Angiography
AJNR 46:1166-1172, Kim,H.,et al, 2025

A 69-Year-Old Woman with Ophthalmoplegia
Neurol 104:e213763, Yu, H & Frey, J, 2025

Risk of Dementia in Individuals with Emergency Department Visits or Hospitalizations Due to Cannabis
JAMA Neurol 82:570-579, Myran,D.T.,et al, 2025

Aspirin Continuation or Discontinuation in Surgically Treated Chronic Subdural Hematoma, A Randomized Clinical Trial
JAMA Neurol 82:551-559, Kamenova,M.,et al, 2025

A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
NEJM 392:2309-2320, Nowak,R.J.,et al, 2025

Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025

Acute Ischemic Stroke Risk Following Cardiac Interventions in the United States From 2016 - 2021
Neurol 105: e213766, Koo,A.B.,et al, 2025

Left Atrial Appendage Occlusion and Its Role in Stroke Prevention
Stroke 56:1928-1937, Seiffge,D.J.,et al, 2025

Intra-Arterial Thrombolysis Following Endovascular Recanalization for Large Vessel Occlusion Stroke
Neurol 105: e213842, Jiang,X.,et al, 2025

Clinicopathological Conference, Powasan Virus Encephalitis
NEJM 393:176-184, Case 19-2025, 2025

Routine Cerebral Embolic Protection during Transcatheter Aortic-Valve Implantation
NEJM 392:2403-2412, 2473, Kharbanda,R.K.,et al, 2025

AAV9-Mediated Gene Therapy for Infantile-Onset Pompes Disease
NEJM 392:2438-2446, 2477, Ma,X.,et al, 2025

Collaboration on the Optimal Timing of Anticoagulation after Ischaemic Stroke and Atrial Fibrillation:A Systematic Review and Prospective Individual Participant Data Meta-Analysis of Randomised Controlled Trials (CATALYST)
Lancet 406:43-51, Dehbi,K-M.,et al, 2025

Outcomes of Patients with Embolic Stroke of Undetermined Source Treated with Antiplatelet Agents or Anticoagulation, A Multicenter Cohort Study
Neurol 105: e213876, Seigler,J.E.,et al, 2025



Showing articles 0 to 50 of 6709 Next >>